APA (7th ed.) Citation

D, S., MA, F., E, H., J, C., P, H., AA, J., . . . C, B. (2019). Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy. Cancer immunology, immunotherapy : CII, 68(11), 1747. https://doi.org/10.1007/s00262-019-02402-z

Chicago Style (17th ed.) Citation

D, Sakellariou-Thompson, Forget MA, Hinchcliff E, Celestino J, Hwu P, Jazaeri AA, Haymaker C, and Bernatchez C. "Potential Clinical Application of Tumor-infiltrating Lymphocyte Therapy for Ovarian Epithelial Cancer Prior or Post-resistance to Chemotherapy." Cancer Immunology, Immunotherapy : CII 68, no. 11 (2019): 1747. https://doi.org/10.1007/s00262-019-02402-z.

MLA (9th ed.) Citation

D, Sakellariou-Thompson, et al. "Potential Clinical Application of Tumor-infiltrating Lymphocyte Therapy for Ovarian Epithelial Cancer Prior or Post-resistance to Chemotherapy." Cancer Immunology, Immunotherapy : CII, vol. 68, no. 11, 2019, p. 1747, https://doi.org/10.1007/s00262-019-02402-z.